Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Projected Market Size and Growth Rates for the Tumor Embolization Devices Market From 2025 To 2029?

The market size for tumor embolization devices has seen significant growth in recent years. The market is expected to rise from $1493.6 billion in 2024 to around $1587.48 billion in 2025, reflecting a compound annual growth rate (CAGR) of 6.3%. The growth experienced in the past is attributed to factors such as the adoption of minimally invasive procedures, advancements in technology, incidence of cancer, and the aging population.

We can anticipate a robust expansion in the market for tumor embolization devices in the forthcoming years, reaching a value of $2254.67 billion in 2029, with a compound annual growth rate (CAGR) of 9.2%. The projected growth for this period is credited to the rise in personalized medicine, combination therapies, image-guided embolization, telemedicine, and remote consultations. The upcoming trends for this forecast period would involve novel embolic agents, transarterial chemoembolization (tace), palliative care embolization, and image-guided procedures.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3352&type=smp

Which Primay Drivers Are Accelerating Growth in the Tumor Embolization Devices Market?

The global increase in cancer cases is expected to fuel the expansion of the tumor embolization devices market in the upcoming years. For instance, Macmillan Cancer Support, the leading healthcare charity in the UK, projected in October 2022 that by 2025, the number of cancer patients will reach 3.5 million, growing to 4 million by 2030, and 5.3 million by 2040. Thus, the escalating incidence of cancer worldwide is predicted to stimulate the demand for the tumor embolization market in the foreseeable future.

Which Primary Segments of the Tumor Embolization Devices Market Are Driving Growth and Industry Transformations?

The tumor embolization devicesmarket covered in this report is segmented –

1) By Type: Radioembolic Agents, Non-radioactive Embolic Agents

2) By Application: Cancer Tumors, Noncancerous Tumors

3) By End User: Hospitals, Cancer Treatment Centers, Intensive Care Units, Surgical Centers

Subsegments:

1) By Radioembolic Agents: Yttrium-90 (Y-90) Microspheres, Holmium-166 Microspheres

2) By Non-radioactive Embolic Agents: Drug-Eluting Beads (DEBs), Microspheres (Polyvinyl Alcohol – PVA Particles), Gelatin Sponges, Liquid Embolic Agents (Onyx, Glue-Based Agents)

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=3352&type=smp

Which Regions Are Key Players in the Growth of the #Which Primay Drivers Are Accelerating Growth in the Tumor Embolization Devices Market?# Market?

North America was the largest region in the tumor embolization devices market in 2024. Asia-Pacific was the second largest region in the tumor embolization devices market. The regions covered in the tumor embolization devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Which Technological Trends Are Reshaping the Tumor Embolization Devices Industry Dynamics?

Key players in the tumor embolization devices market are stepping up their game by developing products such as angiography systems that can amplify the precision and efficiency of treatments aimed at tumors. These systems are advanced imaging devices that enable physicians to see blood vessels and monitor blood circulation within the body. Take for instance Siemens Healthineers, a healthcare firm based in Germany. In June 2022, it introduced the Artis Icono Ceiling, a ceiling-mounted angiography system crafted to elevate the level of precision in tumor embolization and multiple interventional procedures. The Artis Icono Ceiling can rapidly acquire three-dimensional (3D) data, able to capture images at the patient’s head in a mere 2.5 seconds, and from the sides in 4 seconds. Its design reduces motion disturbances and decreases the requirement for contrast media. Versatility is weaved into the Artis Icono Ceiling’s design, making it adaptable for use in a range of specialties, not limited to interventional radiology and cardiology.

View the full report here:

https://www.thebusinessresearchcompany.com/report/tumor-embolization-devices-global-market-report

What Parameters Are Used to Define the Tumor Embolization Devices Market?

Tumor embolization devices are minimally invasive devices used in the treatment of tumors. These devices are used either to shut down the supply of blood to the tumor or to deliver tumor-killing therapy directly to the tumor.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3352

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model